Table 3

90Y-2IT-BAD-m170 dosimetry in 17 patients with androgen-independent metastatic prostate cancer

Gy/GBq (mean ± SD)Range (Gy/GBq)
Tumor (bone), n = 3910.86 ± 5.002.80–21.10
Tumor (nodal), n = 1810.05 ± 5.643.20–25.10
Liver3.95 ± 0.672.62–4.98
Lung1.75 ± 0.381.26–2.49
Kidney2.04 ± 0.581.29–3.64
Body0.62 ± 0.020.58–0.64
Blood-to-bone marrow0.69 ± 0.130.49–0.97
Bone marrow by imaging of 3 lumbar vertebrae1.67 ± 0.341.10–2.40